Zobrazeno 1 - 10
of 196
pro vyhledávání: '"Arvind Chopra"'
Autor:
Arvind Chopra
Publikováno v:
Indian Journal of Rheumatology, Vol 17, Iss 3, Pp 300-305 (2022)
The current report describes successful treatment of a rapidly progressive severe breakthrough COVID-19 in a female physician, a known case of rheumatoid arthritis (RA). She received monoclonal antibody (Mab) combination cocktail (Casirivimab™ plus
Externí odkaz:
https://doaj.org/article/90ff0d9eb80346f09e24640457f72fd5
Autor:
Arvind Chopra, Girish Tillu, Kuldeep Chuadhary, Govind Reddy, Alok Srivastava, Muffazal Lakdawala, Dilip Gode, Himanshu Reddy, Sanjay Tamboli, Manjit Saluja, Sanjeev Sarmukaddam, Manohar Gundeti, Ashwini Kumar Raut, B C S Rao, Babita Yadav, Narayanam Srikanth, Bhushan Patwardhan
Publikováno v:
PLoS ONE, Vol 18, Iss 3, p e0282688 (2023)
ObjectiveEvaluate the efficacy of AYUSH 64, a standard polyherbal Ayurvedic drug in COVID-19.MethodsDuring the first pandemic wave, 140 consenting and eligible hospitalized adult participants with mild-moderate symptomatic disease (specific standard
Externí odkaz:
https://doaj.org/article/decdbed46f1246a994b288b72081b208
Autor:
Arvind Chopra, Preeti Chavan-Gautam, Girish Tillu, Manjit Saluja, Swapnil Borse, Sanjeev Sarmukaddam, Susmita Chaudhuri, BCS Rao, Babita Yadav, Narayanam Srikanth, Bhushan Patwardhan
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Externí odkaz:
https://doaj.org/article/c0891d19ae1d4232b4d1a56cedb95cc5
Autor:
Arvind Chopra, Preeti Chavan-Gautam, Girish Tillu, Manjit Saluja, Swapnil Borse, Sanjeev Sarmukaddam, Susmita Chaudhuri, BCS Rao, Babita Yadav, Narayanam Srikanth, Bhushan Patwardhan
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
IntroductionVaccines have emerged as the most effective tool in the fight against COVID-19. Governments all over the world have rolled out the COVID-19 vaccine program for their populations. Oxford-AstraZeneca COVID-19 vaccine (COVISHIELD™) is wide
Externí odkaz:
https://doaj.org/article/2da26a23a51a44c9b2bab23dda7abda7
Publikováno v:
Complementary Therapies in Medicine, Vol 62, Iss , Pp 102768- (2021)
Objectives: To study the efficacy and safety of Withania somnifera (WS, Ashwagandha) in the prophylaxis against COVID-19 in high risk health care workers (HCW) in comparison to hydroxychloroquine (HCQ). To evaluate the general physical and mental hea
Externí odkaz:
https://doaj.org/article/2643459b68d245ea8779c106766f118c
Publikováno v:
Journal of Ayurveda and Integrative Medicine, Vol 9, Iss 3, Pp 201-208 (2018)
Background: Data on long term use of Ayurvedic drugs is sparse. They may prove useful if combined with modern medicine in certain clinical situations (integrative medicine). We present the results of a long term observational study of RA-1 (Ayurvedic
Externí odkaz:
https://doaj.org/article/71ac61a2fb1d4a08a18c9c49d87b6b40
Autor:
Sytske Anne Bergstra, Cornelia F. Allaart, Rosaline van den Berg, Arvind Chopra, Nimmisha Govind, Tom W. J. Huizinga, Robert B. M. Landewe
Publikováno v:
Arthritis Research & Therapy, Vol 19, Iss 1, Pp 1-6 (2017)
Abstract Background Aiming at rapid decrease of disease activity, there has been a trend to start with higher doses of methotrexate (MTX) in patients newly diagnosed with rheumatoid arthritis (RA), both as monotherapy and in combination with other an
Externí odkaz:
https://doaj.org/article/d228e2e9280d400f93ecc8cfe1cd393a
Autor:
Shelby S Yamamoto, Elaine Yacyshyn, Gian S Jhangri, Arvind Chopra, Divya Parmar, C Allyson Jones
Publikováno v:
PLoS ONE, Vol 14, Iss 12, p e0226738 (2019)
BACKGROUND:Evidence points to a clear link between air pollution exposure and several chronic diseases though investigations regarding arthritis are still lacking. Emerging evidence suggests an association between ambient air pollution and rheumatoid
Externí odkaz:
https://doaj.org/article/d01edfaec97c412c9e23786de7ba8d9c
Autor:
Arvind Chopra
Publikováno v:
Jornal de Pediatria, Vol 90, Iss 5, Pp 431-436 (2014)
Externí odkaz:
https://doaj.org/article/05413fdc938346ea9f0b97893982f897
Publikováno v:
Journal of Ayurveda and Integrative Medicine, Vol 4, Iss 4, Pp 229-236 (2013)
Background: AmrutBhallatak (ABFN02), a ′rasayana′ drug from Ayurveda is indicated in degenerative diseases and arthritis. Objective: To evaluate safety and efficacy of ABFN02 in osteoarthritis (OA) and compare it with Glucosamine sulphate (GS) Ma
Externí odkaz:
https://doaj.org/article/7ce09561fba0445eb90ab618ac8ecd4f